Comparison

Cenisertib European Partner

Item no. TMO-T14925-5mg
Manufacturer TargetMol
CASRN 871357-89-0
Amount 5mg
Category
Type Molecules
Format Powder
Specific against other
Purity 0,98
Smiles N([C@@H]1[C@@H]2C[C@H]([C@@H]1C(N)=O)C=C2)C3=NC(NC4=CC(C)=C(C=C4)N5CCN(C)CC5)=NC=C3F
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 871357-89-0, AS-703569 , R-763
Available
Short Description
Cenisertib is A potent ATP-competitive multi-kinase inhibitor, showing inhibitory effects on the activity of Aurora-kinase-A/B, ABL1, AKT, STAT5, FLT3, as well as kinase inhibitors of FER and its homolog. Cenisertib inhibits the growth of tumor mast cells (MCS) by inhibiting the activity of several different molecular targets. Cenisertib also inhibits tumor growth in pancreatic, breast, colon, ovarian and lung cancer and leukemia in xenograft models.
Shipping
cool pack
Storage
-20°
Target names or alias
AS-703569 , R-763
Molecular Weight
451, 54
Pathway
Tyrosine Kinase/Adaptors|||JAK/STAT signaling|||Cytoskeletal Signaling|||Stem Cells|||Angiogenesis|||PI3K/Akt/mTOR signaling
Target
Bcr-Abl|||STAT|||Akt

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?